Why the study?
The molecular mechanism of modified Huanglian Wendan decoction in the intervention of polycystic ovary syndrome needed investigation.
Design
Network pharmacology and molecular docking study
Key result
Modified Huanglian Wendan decoction targets 155 intersection genes and 54 enriched pathways, including TNF and HIF-1, in the treatment of polycystic ovary syndrome.
Authors
Loading...
Does not support clinical use in PCOS; leaves open prospective validation of identified pathways.
Network pharmacology and molecular docking identified potential active ingredients and targets of modified Huanglian Wendan decoction for PCOS.
Wu et al. (2023) studied polycystic ovary syndrome (PCOS). modified Huanglian Wendan decoction was evaluated on mechanism of action and intersection targets. Modified Huanglian Wendan decoction targets 155 intersection genes and 54 enriched pathways, including TNF and HIF-1, in the treatment of polycystic ovary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: